Interviews with International Experts on State-of-the-Art Evaluation & Management of Valvular Heart Diseases — A Growing Public Health Problem — Now Online

• 

Robot Manipulation

Valvular heart diseases are among the most prominent causes of heart failure and premature death.

New York, NY (PRWEB) June 27, 2012

International experts from around the world discuss state-of-the art evaluation and management of valvular heart disease in 25 interviews posted online on the website of Valves in the Heart of the Big Apple.

Dr. Randy Martin, Piedmont Health Institute, interviewed members of the faculty of Valves in the Heart of the Big Apple VII: Evaluation & Management of Valvular Heart Diseases 2012 during the conference in April in New York City. Attended by over 650 participants, the event was the Fourth Scientific Session of the Heart Valve Society of America (HVSA) and Society of Heart Valve Disease (SHVD).

Valvular heart diseases are among the most prominent causes of heart failure and premature death. It is estimated that more than 10 million Americans have some type of heart valve abnormality, and, in approximately five million, the disease is moderate to severe. Three to four million will require surgery at some time in their lives. These numbers are growing as the population ages — heart valve diseases develop with aging.

Interview topics include:

** Imaging Revolution — Maurice E. Sarano, MD, Mayo Clinic

** New International Heart Valve Society — Jeffrey S. Borer, MD, HVSA president; José-Luis Pomar, MD, PHD, SHVD President; Gino Gerosa, MD, SHVD President-elect

** Robot Manipulation — Tomislav Mihaljevic, MD, Cleveland Clinic; Wiley Nifong, MD, East Carolina Heart Institute; Rakesh Suri, MD, DPhil, Mayo Clinic

** Exercise Testing — Jeffrey S. Borer, MD, SUNY Downstate Medical Center

** Quantitative Mitral Regurgitation — Paul Grayburn, MD, Baylor Heart and Vascular Institute

** Ischemic Mitral Regurgitation — Robert Klautz, MD, Leiden University Medical Centre, The Netherlands

** Percutaneous AVR — Thoralf Sundt, MD, Massachusetts General Hospital; Marat Tuzcu, MD, Cleveland Clinic

** New Aortic Stenosis Treatments — Arash Salemi, MD, NewYork-Presbyterian Hospital, Weill Cornell Medical Center

** Advances in Minimally Invasive Surgery — W. Randolph Chitwood, MD, Brody School of Medicine: Tomislav Mihaljevic, MD, Cleveland Clinic

** Repair Revolution — Hartzell Schaff, MD, Mayo Clinic

** Percutaneous Revolution — Marat Tuzcu, MD, Cleveland Clinic

** Epidemiology — Phyllis Supino, EdD, SUNY Downstate Medical Center

** International Diagnosis and Treatment — Michael Borger, MD, Leipzig Heart Center; Hartzell Schaff, MD, Mayo Clinic

** Tricuspid Regurgitation — Gilles Dreyfus, MD, Centre Cardio-Thoracique de Monaco

** Tricuspid Regurgitation — Patrick McCarthy, Northwestern Feinberg, School of Medicine

** Hybrid OR of the Future — John Elefeteriades, MD, Yale Center for Thoracic Aortic Disease

** Valve Disease/Japan — Yukikatsu Okada, MD, Kobe General Hospital

** Valve Disease/Australia — Trevor Fayers, FRACS, Prince Charles Hospital

** Valve Disease/Hong Kong — Cheuk-Man Yu, MD, Prince of Wales Hospital, The Chinese University of Hong Kong (CUHK)

** Low Gradient Severe Aortic Stenosi — Blase Carabello, MD, Baylor College of Medicine

** Tailoring Bioprostheses to Patients — Johanna J.M. Takkenberg, MD, PhD, Erasmus University Medical Center, Rotterdam

** New Mitral Prostheses — Georg Lutter, MD, Christian-Albrechts-University of Kiel

** Role of 3D Echo — Judy Hung, MD, Massachusetts General Hospital; Sunil Mankad, MD, Mayo Clinic

** New Prosthetic Devices — Michael Borger, MD, Leipzig Heart Center

** Advanced Mitral Repair Reference Center — David Adams, MD, Mount Sinai Medical Center

PDF Print